Formulation of boronic acid compounds
0 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to the formulation of pharmaceutical compounds. More particularly, the invention provides stable, pharmaceutically acceptable compositions prepared from boronic acid compounds and methods for preparing the compositions. The invention also provides novel boronate ester compounds. The invention further provides boronic acid anhydride compounds useful in the methods of the invention.
-
Citations
52 Claims
-
1-32. -32. (canceled)
-
33. A method for formulating a boronic acid compound, the method comprising:
-
(a) preparing an aqueous mixture comprising (i) a boronic acid compound; and
(ii) a compound selected from the group consisting of pinanediol, pinacol, perfluoropinacol, ethylene glycol, diethylene glycol, catechol, 1,2-cyclohexanediol, 1,3-propanediol, 2,3-butanediol, 1,2-butanediol, 1,4-butanediol, glycerol, and diethanolamine; and
(b) lyophilizing the mixture. - View Dependent Claims (34, 35, 36, 37, 38, 39, 40, 41, 42, 50, 51)
-
-
43-49. -49. (canceled)
-
52-92. -92. (canceled)
Specification